TERMINATION Dismissal After Institution of Trial 37 C.F.R. 42.72 | Jun 14, 2022 | PAPER | BOARD |
Compelled Motion in Compliance with Court Order | May 25, 2022 | PAPER | PETITIONER |
Ex 3010 C.A. No. 21-1015 order | May 18, 2022 | EXHIBIT | BOARD |
Ex 3009 e-mail to board | May 18, 2022 | EXHIBIT | BOARD |
Order: Other | Apr 25, 2022 | PAPER | BOARD |
Ex. 3008 | Apr 22, 2022 | EXHIBIT | BOARD |
Order: ORDER Suspending Proceedings 37 C.F.R. § 42.5 | Feb 24, 2022 | PAPER | BOARD |
E-Mail | Feb 18, 2022 | EXHIBIT | BOARD |
Ex 3006 | Feb 17, 2022 | EXHIBIT | BOARD |
Petitioner's Opposition to Patent Owners' Motion for Additional Discovery | Feb 11, 2022 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List as of February 11, 2022 | Feb 11, 2022 | PAPER | PETITIONER |
FDA Orange Book | Feb 11, 2022 | EXHIBIT | PETITIONER |
US 9,024,007 | Feb 11, 2022 | EXHIBIT | PETITIONER |
Sarepta 10-Q Excerpt | Feb 11, 2022 | EXHIBIT | PETITIONER |
E-Mail | Feb 9, 2022 | EXHIBIT | BOARD |
E-Mail | Feb 9, 2022 | EXHIBIT | BOARD |
Petitioner's Objections to Patent Owners' Evidence Submitted with Patent Owners' Motion for Additional Discovery | Feb 9, 2022 | PAPER | PETITIONER |
Ex. 3003 | Feb 3, 2022 | EXHIBIT | BOARD |
Patent Owner's Request for Additional Discovery | Feb 2, 2022 | PAPER | PATENT OWNER |
EXHIBIT 2027 Patent Owner RFP | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
EXHIBIT 2028 Del Complaint | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
EXHIBIT 2029 Patent Claim Chart 361 Patent | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
EXHIBIT 2030 Prescribing Information Vyondys 53 | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
EXHIBIT 2031 Financial Results | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
EXHIBIT 2032 Phase I_II Study of SRP-4053 in DMD Patients | Feb 2, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Feb 2, 2022 | PAPER | PATENT OWNER |
Petitioner's Objections to Patent Owners' Evidence | Jan 24, 2022 | PAPER | PETITIONER |
Patent Owner's Objections to Petitioner's Evidence | Jan 24, 2022 | PAPER | PATENT OWNER |
Ex. 3002 | Jan 12, 2022 | EXHIBIT | BOARD |
DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314 (PUBLIC VERSION) | Jan 12, 2022 | PAPER | BOARD |
Institution Decision: Grant | Jan 7, 2022 | PAPER | BOARD |
Order: Scheduling Order | Jan 7, 2022 | PAPER | BOARD |
Order: Granting Patent Owners Unopposed Motion to Seal and Entering the Default Protective Order | Jan 7, 2022 | PAPER | BOARD |
Patent Owner's Sur-Reply to Petitioner's Reply to 134 Petition | Nov 12, 2021 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owners' Preliminary Response | Nov 5, 2021 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Nov 5, 2021 | PAPER | PETITIONER |
Memorandum Order No. 47 | Nov 5, 2021 | EXHIBIT | PETITIONER |
Memorandum Order No. 72 | Nov 5, 2021 | EXHIBIT | PETITIONER |
Order: Conduct of the Proceeding 37 C.F.R. § 42.5 | Nov 1, 2021 | PAPER | BOARD |
Email: From: Raich, William To: Trials Cc: Bregman, Dion M subject: Sarepta Therapeutics, Inc. v. Nippon Shinyaku Co., Ltd. et al, IPR2021-01134 Date: Monday, October 25, 2021 | Oct 29, 2021 | EXHIBIT | BOARD |
PATENT OWNER NIPPON SHINYAKU CO., LTD.'S UPDATED MANDATORY NOTICES ADDING GUYLAINE HACH�� | Oct 27, 2021 | PAPER | PATENT OWNER |
FINAL REDACTED Version -- Patent Owner Preliminary Response 361 Patent (01134 petition) | Oct 8, 2021 | PAPER | PATENT OWNER |
FINAL SEALED Version -- Patent Owner Preliminary Response 361 Patent (01134 petition) | Oct 8, 2021 | PAPER | PATENT OWNER |
Nippon IPR2021-01134 - Motion to Seal pursuant to 37 CFR 42.55_2 | Oct 8, 2021 | PAPER | PATENT OWNER |
EXHIBIT 2001 ��� Monaco 1988 | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2002 - Beggs Article | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2003 - Aartsma-Rus 2016 | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2004 - YokotaA Renaissance for Antisense Oligonucleotide | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2005 - 361 Pat FH 12.6.15 Original Claims | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2006 - 361 Pat FH Second Prelim Amendment | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2007 - 361 Pat FH 3.25.2016 Office Action | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2008 - 361 Pat FH 7.22.16 Amendment and Response to Office Action | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2009 - 361 Pat FH 10.27.16 Office Action | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2010 - 361 Pat FH 2.27.17 Amendment and Response to Office Action | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2011 - 361 Pat FH Notice of Allowance | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2012 - 361 patent FH 2.16.2015 IDS | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2013 - 9,453,225 PH excerpt | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2014 - 9,447,417 PH excerpt | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2015 - 9,447,416 Pat FH excerpt | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2016 - 948 Pat FH 1.21.16 Response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2017 - 533 App 8-28-2017 response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2018 - 918 Pat. FH excerpt - 4.18.14 | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2019 - 533 App 12-14-2018 response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2020 - 480 App. 2-18-2016 response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2021 - Corey - Nucleic Acid Research 2018 | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2022 - 641 app 9-29-2015 Response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2023 - US20070265215A1 | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2024 - 614 App. 10-16-2015 Office Action | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2025 - 641 App. - 3.16.16 Response | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
EXHIBIT 2026 - Agreement - FILED UNDER SEAL | Oct 8, 2021 | EXHIBIT | PATENT OWNER |
Patent Owner National Center of Neurology and Psychiatry's Mandatory Notice Pursuant to 37 C.F.R. Section 42.8(a)(2) | Aug 4, 2021 | PAPER | PATENT OWNER |
Patent Owner National Center of Neurology and Psychiatry's Power of Attorney | Aug 4, 2021 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Jul 22, 2021 | PAPER | PETITIONER |
Patent Owner Nippon Shinyaku's Mandatory Notice Pursuant to 37 C.F.R. Section 42.8(a)(2) | Jul 21, 2021 | PAPER | PATENT OWNER |
Patent Owner Nippon Shinyaku's Power of Attorney | Jul 21, 2021 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Jul 8, 2021 | PAPER | BOARD |
U.S. Patent No. 9,708,361 | Jun 21, 2021 | EXHIBIT | PETITIONER |
PCT WO 2012/029986 | Jun 21, 2021 | EXHIBIT | PETITIONER |
NS JP App. No. 2010-196032 | Jun 21, 2021 | EXHIBIT | PETITIONER |
English Translation for JP Provisional | Jun 21, 2021 | EXHIBIT | PETITIONER |
English Translation of PCT WO 2012/029986 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Certificate JP 2010-196032 | Jun 21, 2021 | EXHIBIT | PETITIONER |
PCT certificate JP 2011-070318 | Jun 21, 2021 | EXHIBIT | PETITIONER |
'361 Patent FH excerpts | Jun 21, 2021 | EXHIBIT | PETITIONER |
Popplewell 2010 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Sazani 2010 | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2010/0168212 (Popplewell) | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2010/0130591 (Sazani US) | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2013/0109091 (Baker) | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2012/0190728 (Bennett) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Bushby 2010 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Kinali 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Hoffman 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Wilton 2008 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Arechavala-Gomeza 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Ginjaar 2000 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Wilton 2005 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Wilton 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Muntoni 2010 | Jun 21, 2021 | EXHIBIT | PETITIONER |
van Deutekom 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Goemans 2011 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Cirak 2011 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Nakamura 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Yokota 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Aartsma-Rus 2009(b) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Aartsma-Rus 2009(c) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Chan 2006 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Summerton 1997(a) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Adams 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2003/0166588 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Aartsma-Rus 2005 | Jun 21, 2021 | EXHIBIT | PETITIONER |
WO 2004/083432 (Leiden) | Jun 21, 2021 | EXHIBIT | PETITIONER |
WO 2006/000057 (Wilton 1 PCT) | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2007/0082861 (Matsuo 5) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Popplewell 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Moulton 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
WO 2011/057350 (Wilton 2 PCT) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Summerton 1999 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Muntoni 2008 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Aartsma-Rus 2007 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Trollet 2009 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Prosensa and GlaxoSmithKline | Jun 21, 2021 | EXHIBIT | PETITIONER |
Vickers 2000 | Jun 21, 2021 | EXHIBIT | PETITIONER |
U.S. Patent No. 10,407,461 | Jun 21, 2021 | EXHIBIT | PETITIONER |
OA 14-776,533 dated Nov 16 2017 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Abandonment 14-776,533 dated Mar 20, Apr 5 2019 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Interference 106,007 Paper 476 May 12 2016 | Jun 21, 2021 | EXHIBIT | PETITIONER |
McClorey 2006 | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 61-591,354 (PRO6) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Mann 2002 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Albert 4th Ed (Ch. 4 + Ch. 6) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Douglas and Wood 2013 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Dominski & Kole (1993) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Dominski & Kole (1994) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Sierakowska et al. (1996) | Jun 21, 2021 | EXHIBIT | PETITIONER |
Aartsma-Rus 2002 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Bremmer-Bout et al. (2004) | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2009/0131624 A1 | Jun 21, 2021 | EXHIBIT | PETITIONER |
US 2009/0088562 A1 | Jun 21, 2021 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,185,444 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Experimental Report filed in EP 3018211 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Declaration of Dr. Ueda filed in EP 3018211 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Preliminary Opinion from OD in EP 3018211 | Jun 21, 2021 | EXHIBIT | PETITIONER |
Hayes Greenhill Declaration | Jun 21, 2021 | EXHIBIT | PETITIONER |
Corey Declaration | Jun 21, 2021 | EXHIBIT | PETITIONER |
Petition for Inter Partes Review | Jun 21, 2021 | PAPER | PETITIONER |
Petitioner Sarepta Therapeutics, Inc.'s Power of Attorney and Designation of Lead and Backup Counsel | Jun 21, 2021 | PAPER | PETITIONER |